Reuters logo
BRIEF-Immusant announces publication of positive data from phase 1 trials of Nexvax2
May 12, 2017 / 11:07 AM / 4 months ago

BRIEF-Immusant announces publication of positive data from phase 1 trials of Nexvax2

May 12 (Reuters) -

* Immusant announces publication of positive data from phase 1 trials of Nexvax2 in celiac disease patients Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below